ArticleInternational immunopharmacology2024
EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon α-accelerated murine lupus.
Paul M Gallo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.